Shareholders

Archimica is owned by TowerBrook Capital Partners, L.P. TowerBrook is a private equity firm with more than $2.5 billion under management. The firm has offices in London and New York and focuses on making investments in European and North American companies. TowerBrook pursues control oriented private equity investments in large and middle market companies, partnering with highly capable management teams and seeking situations characterized by complexity.

The TowerBrook management team has a broad range of experience in the management of health related business. TowerBrook's management team has been involved in investments in biopharmaceutical development, medical device manufacture and biotechnology.

www.towerbrook.com